Chronic mucocutaneous candidiasis: what can we conclude about IL-17 antagonism? - Wikidata - awgldk - TriplyDB

Chronic mucocutaneous candidiasis: what can we conclude about IL-17 antagonism?

Chronic mucocutaneous candidiasis: what can we conclude about IL-17 antagonism?

http://www.wikidata.org/entity/Q47706029

about

Chronic mucocutaneous candidiasis: what can we conclude about IL-17 antagonism?

http://www.wikidata.org/entity/Q47706029

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Chronic mucocutaneous candidiasis: what can we conclude about IL-17 antagonism?

@en

Chronic mucocutaneous candidiasis: what can we conclude about IL-17 antagonism?

@nl

type

label

Chronic mucocutaneous candidiasis: what can we conclude about IL-17 antagonism?

@en

Chronic mucocutaneous candidiasis: what can we conclude about IL-17 antagonism?

@nl

prefLabel

Chronic mucocutaneous candidiasis: what can we conclude about IL-17 antagonism?

@en

Chronic mucocutaneous candidiasis: what can we conclude about IL-17 antagonism?

@nl

P1433

Q47706029-B2EB1C49-812C-467B-973F-65CB00793FCF

P1476

Q47706029-C9A0575E-C4FC-4B04-940B-402B9481D2CB

P2093

Q47706029-2625F063-ACCC-4260-9A0C-C7ECB60A87BD

P2860

Q47706029-05E28023-49F8-4997-B249-4BFE3B8FC521

Q47706029-08BE9AAC-826D-4B1F-B7B3-2246E5A408F1

Q47706029-098D534E-A144-4FB4-BB47-7FFBA8134253

Q47706029-0BB3A98E-3C65-44EB-930A-FC20E1FDE121

Q47706029-0C5F4F3B-D0C5-4CBB-BC96-DBF89F5349A6

Q47706029-0DC0FAC1-1B33-4131-B5F5-0021CC5DC63A

Q47706029-101C3B92-C8B1-4415-98A9-B47ACE9D978C

Q47706029-10C7652B-A661-4C56-BD0D-E1DAA643A999

Q47706029-118FDB7B-FF98-44B4-BE98-689DF8E551BA

Q47706029-13B8DB04-49FF-49BE-9D97-4D2D73CD68D7

P304

Q47706029-7FE627E6-F931-4D81-A238-A6981D11E344

P31

Q47706029-E2577391-803E-402E-91F1-F40A24B1C432

P356

Q47706029-4D257545-98B2-4677-B899-DBC6F54783D6

P433

Q47706029-3D6BD2E9-78C0-41EF-A23C-89678D4C9EB6

P478

Q47706029-DCBFE359-BBC9-4B07-8DDC-E191ECAEF997

P50

Q47706029-6B0D8394-2D76-42E8-A35F-79BCF4BF4771

Q47706029-F12BF539-897E-4A8C-94B0-6613860D0009

P577

Q47706029-691D35DC-F663-4229-A23F-891901BB56ED

P698

Q47706029-F6AF200E-B25B-4895-A9D3-75317454C989

P356

09546634.2017.1398396

P1433

Journal of Dermatological Treatment

P1476

Chronic mucocutaneous candidiasis: what can we conclude about IL-17 antagonism?

@en

P2093

Kevin K Veverka

http://www.w3.org/2001/XMLSchema#string

P2860

Human dectin-1 deficiency and mucocutaneous fungal infections

A homozygous CARD9 mutation in a family with susceptibility to fungal infections

IL-23/IL-17A Dysfunction Phenotypes Inform Possible Clinical Effects from Anti-IL-17A Therapies

A Novel Heterozygous Mutation in the STAT1 SH2 Domain Causes Chronic Mucocutaneous Candidiasis, Atypically Diverse Infections, Autoimmunity, and Impaired Cytokine Regulation

Clinical and immunological data of nine patients with chronic mucocutaneous candidiasis disease

Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines.

Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I

Deep dermatophytosis and inherited CARD9 deficiency

Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity.

Chronic mucocutaneous candidiasis: a case with exuberant cutaneous horns in nipples.

P304

475-480

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/09546634.2017.1398396

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P50

Steven R. Feldman

Kevin K Veverka

P577

2017-10-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29076381

http://www.w3.org/2001/XMLSchema#string